Schilder, Anne G. M.
Wolpert, Stephan http://orcid.org/0000-0001-5385-8770
Saeed, Shakeel
Middelink, Leonie M.
Edge, Albert S. B. http://orcid.org/0000-0001-8641-755X
Blackshaw, Helen
Schilder, Anne
Middelink, Leonie
Edge, Albert
Bibas, Athanasios
Arram, Elizabeth
Bilhet, Asger
Cooper, Hannah
Dalhoff, Ernst
van Diggelen, Femke
Rutten, Rolf Jan
van Es, Helmuth
Hojgaard, Karin
Iliadou, Eleftheria
Yildirim, Omursen
Khalil, Sherif
Kikidis, Dimitris
Lowenheim, Hubert
Markatos, Nikos
Mueller, Marcus
Schade-Mann, Thore
Schneider, Fritz
Vardonikolaki, Katerina
Wilke, August
Pastiadis, Kostas
Bibas, Athanasios G. http://orcid.org/0000-0002-1992-6511
,
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme
Article History
Received: 10 November 2021
Accepted: 1 February 2024
First Online: 1 March 2024
Competing interests
: A.G.M. Schilder advises hearing industry on clinical trial design and delivery. A.S.B. Edge is a consultant and shareholder of Audion Therapeutics BV. L.M. Middelink is consultant to Audion Therapeutics BV. The remaining authors declare no competing interests